Abstract
Objective: To observe the effect of Fuzheng Kangbai Granule (FZKBG) on long-term survival of patients with acute leukemia, and to study its mechanism in treating minimal residual leukemia.Methods: FZKBG was used to treat 90 cases of completely remitted acute leukemia to observe the effect of treatment on 5-year event free interval (EFI), over survival (OS) and the immune function of patients.Results: Five-year EFI and OS of the 90 cases were 62.4% and 77.2% respectively, and the immune functions after FZKBG therapy were improved significantly.Conclusion: FZKBG could increase the 5-year EFI and 5-year OS, which might be reached through improving immune function of patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gale RP, Bulturini T. Is transplantation in first remission AML more effective than in advanced leukemia? Leukemia Res 1989; 13(12): 1035.
Gale RP, Ben R. Autotransplants in leukemia: current state, future progress. Leukemia Res 1991; 15(9):781.
Wolin MJ, Gale RP. Therapy of acute myelogenous leukemia: understanding the question, understanding the answer. Leukemia Res 1997; 21(1): 3–8.
Wernli M, Tidelli A, Fliederer R, et al. Intensive induction/consolidation therapy without maintenance in adult a-cute lymphoblastic leukemia: a pilot assessment. Br J Hematol 1994; 87(1): 39–43.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rou, M., Feng, L., Jingmin, Y. et al. Clinical study on effect of Fuzheng Kangbai Granule
on long-term survival of patients with acute leukemia) on long-term survival of patients with acute leukemia.
CJIM 4, 259–262 (1998). https://doi.org/10.1007/BF02935470
Issue Date:
DOI: https://doi.org/10.1007/BF02935470